Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
To facilitate the implementation of Quality by Design (QbD) for abbreviated new drug application (ANDA), Office of Generic Drugs (OGD) has developed mock QbD examples for immediate release (IR) and modified release (MR) dosage forms. This presentation will provide insight into OGD’s current thinking on QbD filing requirement and definition of some QbD nomenclatures. The Question-based Review (QbR) system is to be revised in 2011 and 2012 and is expected to be fully implemented by January 2013. This presentation will also discuss some practical tools and types of pharmaceutical development studies ANDA applicants may use as they implement QbD in their pharmaceutical development process.
Professional Development Hours
0.50 PDHs
Presenter(s):
Preview Presentation:
Watch the following preview of this presentation.
Would you like to access this content?
No problem. You just have to complete the following steps.
You have completed 0 of 2 steps.
-
Log in
You must be logged in to view this content. Log in now.
-
Purchase Technical Presentation
You must purchase this technical presentation using one of the options below.
If you already purchased this content recently, please click here to refresh the system's record of ownerships.
Pricing
| Credits | 0.5 Use credits |
| List Price | $25.00 Buy now |
| AIChE Members | $15.00 Buy now |
| AIChE Undergraduate Student Members | Free Free access |
| AIChE Graduate Student Members | $15.00 Buy now |
Related Topics: